Contemporary OB/GYN week in review: Pregnancy prevention, postpartum depression, and more

News
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Contemporary OB/GYN week in review: Pregnancy prevention, postpartum depression, and more

Contemporary OB/GYN week in review: Pregnancy prevention, postpartum depression, and more

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, July 22 - Friday, July 26, 2024), and click each link to read and watch anything you may have missed.

1.) FDA approves femlyv as the first orally disintegrating tablet for pregnancy prevention

Femlyv, containing norethindrone acetate and ethinyl estradiol, offers a new oral contraceptive option for individuals with swallowing difficulties, expanding access and convenience.

Click here for the full article.

2.) First patient dosed in RECONNECT trial of RE104 for postpartum depression

Reunion Neuroscience Inc. initiates phase 2 trial of RE104, a novel short-duration psychedelic treatment for postpartum depression, aiming to provide rapid and effective relief for affected mothers.

Click here for the full article.

3.) Unexpected RBC antibodies found in 1.85% of pregnant women

A recent study reveals that unexpected red blood cell antibodies are present in 1.85% of pregnant women, highlighting the need for potential interventions to manage fetal anemia.

Click here for the full article.

4.) ZY5301 tablet effective for chronic pelvic pain

These results indicated a significant reduction of CPP from 12 weeks of ZY5301 treatment. Investigators recommended a ZY5301 600 mg/d dose be investigated in a phase 3 trial.

Click here for the full article.

5.) ACOG release new practice update on biomarker testing for hypertensive disorders in pregnancy

Padmashree Woodham, MD, professor of maternal-fetal medicine at Wellstar Medical College of Georgia Health, outlines the new ACOG practice update on biomarker testing for risk assessment of hypertensive disorders in pregnancy.

Click here for the full article.

Recent Videos
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
Screening-to-diagnosis interval vital for gestational diabetes outcomes | Image Credit: ultracon2024.eventscribe.net
Henri M. Rosenberg, MD
Medical experts personalize contraceptive options for complex cases | Image Credit: findcare.ahn.org
Study explores the limits of neighborhood data in predicting preterm birth | Image Credit: linkedin.com
Integrase inhibitors not linked to neonatal weight | Image Credit: linkedin.com
How AI is revolutionizing prenatal detection of congenital heart defects | Image Credit: mfmnyc.com/team.
Related Content
© 2025 MJH Life Sciences

All rights reserved.